Source: Pharmacy Times articles
In addition to improved progression-free survival, patients treated with this regimen also showed improved complete response or stronger and were minimal residual disease-negative.
Read More
by | Feb 12, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
In addition to improved progression-free survival, patients treated with this regimen also showed improved complete response or stronger and were minimal residual disease-negative.
Read More